Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001193805-14-001168)

Filing Details

Accession Number:: 0001193805-14-001168
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-06-03 22:50:51
Reporting Period:: 2014-05-30

Filing Date:: 2014-06-03
Accepted Time:: 2014-06-03 21:50:51
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1438533	Retrophin Inc.	RTRX	Pharmaceutical Preparations (2834)	262383102

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1525354	Martin Shkreli	C/O Retrophin, Inc. 777 Third Avenue, 22Nd Floor New York NY 10017	Chief Executive Officer	Yes	Yes	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2014-05-30	50,000	$14.62	3,032,680	No	4	J	Direct
Common Stock	Acquisiton	2014-05-30	126,388	$14.62	3,159,068	No	4	J	Direct
Common Stock	Disposition	2014-05-30	292,400	$15.14	2,866,668	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	J	Direct
No	4	J	Direct
No	4	S	Direct

Footnotes

Such shares were previously delivered to a third party in consideration for services that were never rendered and were subsequently returned to the reporting person.
Such shares were previously delivered to a third party in consideration for services that were never rendered and were deemed returnable to the reporting person in accordance with an arbitration ruling.